These Guidelines represent the third time that the ESC and EACTS have brought together
cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body …

Background New-generation drug-eluting stents (DES) have mostly been investigated in
head-to-head non-inferiority trials against early-generation DES and have typically shown …

always refer to the full text version, which is freely available on the ESC and EACTS
websites. The National Societies of the ESC are encouraged to endorse, translate, and …

5. Leczenie.............................................................. 1225 5.1. Farmakoterapia
niedokrwienia...................... 1225 5.1. 1. Ogólne leczenie objawowe................. 1225 5.1. 2 …

Aims Stenting an angiographically intermediate but functionally non-significant stenosis is
controversial. Nevertheless, it has been questioned if deferral of a functionally non …

Члены Рабочей группы подтвердили отсутствие финансовой поддержки/конфликта
интересов. В случае сообщения о наличии конфликта интересов член (ы) Рабочей …

2020 Clinical practice guidelines for Acute coronary syndrome without ST segment elevation |
Barbarash | Russian Journal of Cardiology Russian Journal of Cardiology eng | рус User ISSN …

Background Results of trials and registry studies have shown lower long-term mortality after
coronary-artery bypass grafting (CABG) than after percutaneous coronary intervention (PCI) …

Background: The use of drug-eluting stents (DES) in patients at high risk of bleeding or
thrombosis has not been prospectively studied; limited data are available in patients who …

Objectives: This study sought to investigate the ischemic and bleeding outcomes of patients
fulfilling high bleeding risk (HBR) criteria who were randomized to zotarolimus-eluting …